Literature DB >> 36205839

Biomarkers associated with coronary high-risk plaques.

Akihiro Nakajima1,2, Peter Libby3, Satoru Mitomo2, Haruhito Yuki2, Makoto Araki1, Lena Marie Seegers1, Iris McNulty1, Hang Lee4, Midori Ishibashi5, Kazuna Kobayashi6, Jouke Dijkstra7, Toru Ouchi2, Hirokazu Onishi2, Hiroto Yabushita2, Satoshi Matsuoka2, Hiroyoshi Kawamoto2, Yusuke Watanabe2, Kentaro Tanaka2, Shengpu Chou8, Tomohiko Sato2, Toru Naganuma2, Masaaki Okutsu2, Satoko Tahara2, Naoyuki Kurita2, Shotaro Nakamura2, David J Kuter9, Sunao Nakamura10, Ik-Kyung Jang11,12.   

Abstract

Vascular inflammation, lipid metabolism, and thrombogenicity play a key role not only in atherogenesis but also in the development of acute coronary syndromes. Biomarkers associated with coronary high-risk plaques defined according to intravascular imaging have not been systematically studied. A total of 69 patients with coronary artery disease who underwent both optical coherence tomography and intravascular ultrasound imaging, and who provided blood specimens were included. Comprehensive biomarkers for inflammation, lipid, and coagulation were analyzed. Composite models sought biomarker patterns associated with thin-cap fibroatheroma (TCFA) and "high-risk plaques" (TCFA and large plaque burden). Two different composite models were developed for TCFA, based on the finding that high sensitivity C-reactive protein (hsCRP), plasminogen activator inhibitor-1, fibrinogen, IL-6, homocysteine and amyloid A levels were elevated, and high-density lipoprotein cholesterol (HDL) and bile acid levels were decreased in these patients. Both composite models were highly accurate for detecting patients with TCFA (area under curve [AUC]: 0.883 in model-A and 0.875 in model-B, both p < 0.001). In addition, creatinine, hsCRP, fibrinogen, tumor necrosis factor-α, IL-6, homocysteine, amyloid A, HDL, prothrombin, and bile acid were useful for detecting patients with "high-risk plaques". Two composite models were highly accurate for detection of patients with "high-risk plaques" (AUC: 0.925 in model-A and 0.947 in model-B, both p < 0.001). Biomarkers useful for detection of patients with high-risk coronary plaques defined according to intravascular imaging have been identified. These biomarkers may be useful to risk stratify patients and to develop targeted therapy.Clinical Trial Registration https://www.umin.ac.jp/ctr/ , UMIN000041692. Biomarkers and high-risk plaques hsCRP, PAI-1, fibrinogen, IL-6, homocysteine, amyloid A, HDL, and bile acid were useful for detecting patients with TCFA. hsCRP, fibrinogen, IL-6, homocysteine, amyloid A, creatinine, TNFα, HDL, prothrombin, and bile acid were useful for detecting patients with "high-risk plaques" (plaque which has both TCFA and large plaque burden). White arrowhead denotes TCFA. Red and green dashed lines denote lumen area and external elastic membrane area, respectively.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Biomarker; Coronary artery disease; Intravascular ultrasound; Optical coherence tomography; Vulnerable plaque

Year:  2022        PMID: 36205839     DOI: 10.1007/s11239-022-02709-2

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   5.221


  32 in total

Review 1.  American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.

Authors:  G S Mintz; S E Nissen; W D Anderson; S R Bailey; R Erbel; P J Fitzgerald; F J Pinto; K Rosenfield; R J Siegel; E M Tuzcu; P G Yock
Journal:  J Am Coll Cardiol       Date:  2001-04       Impact factor: 24.094

2.  Prevalence and Predictors of Multiple Coronary Plaque Ruptures: In Vivo 3-Vessel Optical Coherence Tomography Imaging Study.

Authors:  Rocco Vergallo; Shiro Uemura; Tsunenari Soeda; Yoshiyasu Minami; Jin-Man Cho; Daniel S Ong; Aaron D Aguirre; Lei Gao; Luigi M Biasucci; Filippo Crea; Bo Yu; Hang Lee; Chong-Jin Kim; Ik-Kyung Jang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-09-15       Impact factor: 8.311

3.  Triglyceride reduction in secondary atherosclerotic cardiovascular disease prevention: core concepts in contemporary therapeutic targeting.

Authors:  Patrick R Lawler; Robert S Rosenson; Dennis T Ko
Journal:  Eur Heart J       Date:  2020-04-14       Impact factor: 29.983

4.  Clinical Significance of Lipid-Rich Plaque Detected by Optical Coherence Tomography: A 4-Year Follow-Up Study.

Authors:  Lei Xing; Takumi Higuma; Zhao Wang; Aaron D Aguirre; Kyoichi Mizuno; Masamichi Takano; Harold L Dauerman; Seung-Jung Park; Yangsoo Jang; Chong-Jin Kim; Soo-Joong Kim; So-Yeon Choi; Tomonori Itoh; Shiro Uemura; Harry Lowe; Darren L Walters; Peter Barlis; Stephen Lee; Amir Lerman; Catalin Toma; Jack Wei Chieh Tan; Erika Yamamoto; Krzysztof Bryniarski; Jiannan Dai; Thomas Zanchin; Shaosong Zhang; Bo Yu; Hang Lee; James Fujimoto; Valentin Fuster; Ik-Kyung Jang
Journal:  J Am Coll Cardiol       Date:  2017-05-23       Impact factor: 24.094

5.  A prospective natural-history study of coronary atherosclerosis.

Authors:  Gregg W Stone; Akiko Maehara; Alexandra J Lansky; Bernard de Bruyne; Ecaterina Cristea; Gary S Mintz; Roxana Mehran; John McPherson; Naim Farhat; Steven P Marso; Helen Parise; Barry Templin; Roseann White; Zhen Zhang; Patrick W Serruys
Journal:  N Engl J Med       Date:  2011-01-20       Impact factor: 91.245

Review 6.  The myth of the "vulnerable plaque": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment.

Authors:  Armin Arbab-Zadeh; Valentin Fuster
Journal:  J Am Coll Cardiol       Date:  2015-01-16       Impact factor: 24.094

Review 7.  Optical Coherence Tomography of Plaque Vulnerability and Rupture: JACC Focus Seminar Part 1/3.

Authors:  Aaron D Aguirre; Armin Arbab-Zadeh; Tsunenari Soeda; Valentin Fuster; Ik-Kyung Jang
Journal:  J Am Coll Cardiol       Date:  2021-09-21       Impact factor: 24.094

Review 8.  Association of inflammatory markers with angiographic severity and extent of coronary artery disease.

Authors:  Maria Drakopoulou; Konstantinos Toutouzas; Elli Stefanadi; Eleftherios Tsiamis; Dimitris Tousoulis; Christodoulos Stefanadis
Journal:  Atherosclerosis       Date:  2009-02-07       Impact factor: 5.162

Review 9.  The changing landscape of atherosclerosis.

Authors:  Peter Libby
Journal:  Nature       Date:  2021-04-21       Impact factor: 69.504

10.  Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial.

Authors:  Elvin Kedhi; Balazs Berta; Tomasz Roleder; Renicus S Hermanides; Enrico Fabris; Alexander J J IJsselmuiden; Floris Kauer; Fernando Alfonso; Clemens von Birgelen; Javier Escaned; Cyril Camaro; Mark W Kennedy; Bruno Pereira; Michael Magro; Holger Nef; Sebastian Reith; Arif Al Nooryani; Fernando Rivero; Krzysztof Malinowski; Giuseppe De Luca; Hector Garcia Garcia; Juan F Granada; Wojciech Wojakowski
Journal:  Eur Heart J       Date:  2021-12-01       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.